Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4201 AL 4215

Microglia-Mediated Neuroprotection, TREM2, and Alzheimer's Disease: Evidence From Optical Imaging

Condello C, Yuan P, Grutzendler J.

Biol Psychiatry. 2018 Feb 15;83(4):377-387. doi: 10.1016/j.biopsych.2017.10.007. Epub 2017 Oct 14.

Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease

Seo EJ, Fischer N, Efferth T.

Pharmacol Res. 2018 Mar;129:262-273. doi: 10.1016/j.phrs.2017.11.030. Epub 2017 Nov 24.

Intranasal insulin in Alzheimer's disease: Food for thought

Chapman CD, Schiöth HB, Grillo CA, Benedict C.

Neuropharmacology. 2018 Jul 1;136(Pt B):196-201. doi: 10.1016/j.neuropharm.2017.11.037. Epub 2017 Nov 24.

The Alzheimer's Prevention Initiative Generation Program: Evaluating CNP520 Efficacy in the Prevention of Alzheimer's Disease

Lopez Lopez C, Caputo A, Liu F, Riviere ME, Rouzade-Dominguez ML, Thomas RG, Langbaum JB, Lenz R, Reiman EM, Graf A, Tariot PN.

J Prev Alzheimers Dis. 2017;4(4):242-246. doi: 10.14283/jpad.2017.37.

Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease

Alam J, Blackburn K, Patrick D.

J Prev Alzheimers Dis. 2017;4(4):273-278. doi: 10.14283/jpad.2017.41.

Multimedia Aided Consent for Alzheimer's Disease Research

Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV.

Clin Gerontol. 2018 Jan-Feb;41(1):20-32. doi: 10.1080/07317115.2017.1373177. Epub 2017 Nov 28.

Editorial: Multi-target Drug Discovery - Part II

Chen JN.

Curr Top Med Chem. 2017 Nov 20;17(28):3081-3083. doi: 10.2174/156802661728171120143727.

Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer's disease

Camargo LC, Campos GAA, Galante P, Biolchi AM, Gonçalves JC, Lopes KS, Mortari MR.

Neuropeptides. 2018 Feb;67:79-86. doi: 10.1016/j.npep.2017.11.010. Epub 2017 Nov 28.

Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer's disease: A neuropharmacological review of their bioactive constituents

Gorji N, Moeini R, Memariani Z.

Pharmacol Res. 2018 Mar;129:115-127. doi: 10.1016/j.phrs.2017.12.003. Epub 2017 Dec 5.

ATP-binding cassette transporter-2 (ABCA2) as a therapeutic target

Davis W Jr, Tew KD.

Biochem Pharmacol. 2018 May;151:188-200. doi: 10.1016/j.bcp.2017.11.018. Epub 2017 Dec 6.

Comparison of blood-brain barrier penetration efficiencies between linear and cyclic all-d-enantiomeric peptides developed for the treatment of Alzheimer's disease

Schartmann E, Schemmert S, Ziehm T, Leithold LHE, Jiang N, Tusche M, Joni Shah N, Langen KJ, Kutzsche J, Willbold D, Willuweit A.

Eur J Pharm Sci. 2018 Mar 1;114:93-102. doi: 10.1016/j.ejps.2017.12.005. Epub 2017 Dec 7.

The past, present, and future of disease-modifying therapies for Alzheimer's disease

Suzuki K, Iwata A, Iwatsubo T.

Proc Jpn Acad Ser B Phys Biol Sci. 2017;93(10):757-771. doi: 10.2183/pjab.93.048.

Amylin in Alzheimer's disease: Pathological peptide or potential treatment?

Mietlicki-Baase EG.

Neuropharmacology. 2018 Jul 1;136(Pt B):287-297. doi: 10.1016/j.neuropharm.2017.12.016. Epub 2017 Dec 9.

Suvorexant for the treatment of insomnia in patients with Alzheimer's disease

Hamuro A, Honda M, Wakaura Y.

Aust N Z J Psychiatry. 2018 Feb;52(2):207-208. doi: 10.1177/0004867417747402. Epub 2017 Dec 14.

Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?

Becker RE, Kapogiannis D, Greig NH.

Alzheimers Dement. 2018 Apr;14(4):431-443. doi: 10.1016/j.jalz.2017.11.007. Epub 2017 Dec 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias